ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
28 announcements with these filters
Integrated Proteins Ltd has announced its 33rd Annual General Meeting scheduled for September 30, 2026, via video conferencing to transact business including financial statement adoption.
Integrated Proteins Limited has released its 33rd Annual Report for the financial year 2025-26, containing financial statements and details for the upcoming annual general meeting.
Integrated Proteins Limited has been assigned a new ISIN, INE177M01021, following a stock split. The change is effective from September 4, 2026.
Integrated Proteins Ltd has fixed September 4, 2026, as the record date for splitting its equity shares from a face value of ₹10 to ₹1 each.
Integrated Proteins Limited announced the re-appointment of Hiren Dhirajlal Shah as Managing Director for five years. Nitish Pratapray Mehta was appointed as Non-Executive Independent Director.
Integrated Proteins Limited held its Extraordinary General Meeting (EGM) on August 20, 2026. Shareholders considered resolutions including a share split and director appointments.
Integrated Proteins Ltd reported revenue from operations of ₹10.5 Cr and net profit of ₹0.4 Cr for Q1 FY27.
Integrated Proteins Ltd scheduled a board meeting on August 14, 2026, to approve the company's financial results for the quarter ended June 30, 2026.
Integrated Proteins Limited issued a notice for an Extraordinary General Meeting (EGM) on August 20, 2026, to discuss share splitting and director regularizations.
Ms. Shivangi Paliwal has resigned as Company Secretary and Compliance Officer of Integrated Proteins Limited, effective July 27, 2026.
Integrated Proteins Limited announced the re-designation of Mr. Hiren Dhirajlal Shah as Chairman and Managing Director. The company also scheduled an EGM for August 20, 2026.
Integrated Proteins Ltd has filed its quarterly shareholding pattern statement for the period ended June 30, 2026, as per SEBI regulations.
Integrated Proteins announced a board reorganization with the resignation of three directors. Simultaneously, Sandeep Mahadik, Hiren Shah, and Nitesh Mehta were appointed to the board.
Integrated Proteins Ltd disclosed its board meeting outcome, approving a Rs.25 Crore share split and reclassifying promoters. Several directors resigned and new appointments were made.
Integrated Proteins approved a 1:10 stock split, reducing face value to Re. 1. The board also cleared promoter reclassification and several senior leadership changes.
Integrated Proteins Ltd postponed its board meeting to 9 July 2026, extending the trading window until after Q2‑2026 results. Agenda includes a stock split and other business.
Integrated Proteins Ltd received requests for promoter reclassification under SEBI Reg 31A. The move, if approved, would shift certain shareholders from promoter to public category.
Integrated Proteins Ltd scheduled a board meeting for July 3, 2026. The board will consider the sub-division of equity shares.
Managing Director Mr. Karanj Dharmeshbhai Doshi has resigned due to personal reasons. His resignation is effective from June 29, 2026.
Integrated Proteins Limited appointed Ms. Shivangi Paliwal as Company Secretary following Mr. Girish Kalwani's resignation. The transition ensures leadership continuity in compliance and corporate governance.
Integrated Proteins Limited approved the resignation of CS Girish Kalwani and appointed Ms. Shivangi Paliwal as Company Secretary. These changes were finalized during the May 30 board meeting.
Integrated Proteins Limited submitted revised financial results for FY 2026 to include tax provisions. Net profit was adjusted to Rs. 19.00 Lakhs from Rs. 23.14 Lakhs.
Integrated Proteins Ltd reported revenue from operations of ₹5.7 Cr (-73.5% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q4 FY26.
Integrated Proteins Ltd approved its FY26 audited results reporting a total income of ₹9.94 Crore. The company achieved a net profit of ₹0.23 Crore.
Integrated Proteins Limited has rescheduled its board meeting to May 26, 2026. Directors will approve standalone audited financial results for the 2026 fiscal year.
Integrated Proteins scheduled a board meeting for May 23, 2026, to approve annual audited financial results. The trading window remains closed until results are declared.
Integrated Proteins Limited confirmed it does not qualify as a 'Large Corporate' under SEBI's framework as of March 31, 2026. The company reported zero outstanding borrowings and is therefore exempt from mandatory incremental debt sourcing requirements from the bond market.
Integrated Proteins Ltd informed BSE that Regulation 24A regarding Annual Secretarial Compliance Reports is not applicable for FY2026. The company qualifies for exemption under Regulation 15(2) as its paid-up capital is below Rs.10 Crore and net worth is below Rs.25 Crore. This is a routine regulatory compliance update.